Thanks for the link drafter.........BLT chart continues after...

Thanks for the link drafter.........


BLT chart continues after this weeks trading to remain very bullish short, medium and longterm. The presentation by Alnylam Pharmaceuticals
at the ASCO Meeting on Saturday June 4th re the full results of the ""Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with
liver involvement. (Abstract #3025) presented by
Andres Cervantes "" and the presentation by Silence Therapeutics on Monday June 6th "'First-in-human phase I study of Atu027, a liposomal small interfering RNA formulation,
targeting protein kinase N3 (PKN3) in patients with advanced solid tumors. (Abstract #3057) presented by
Dirk Strumberg""
may be the catylist for a rerate of this stock and the sector it operates in. Lets see how we go, Goodluck
.....................................................

Alnylam Pharmaceuticals

http://finance.yahoo.com/news/Alnylams-ALNVSP-Abstract-bw-2839501193.html?x=0&.v=1

(pdf file Saturday June 4th 2011 Page 68)..........
http://chicago2011.asco.org/MeetingProgram.aspx
.....................................................

Silence Therapeutics

http://finance.yahoo.com/news/Silence-Therapeutics-to-prnews-45970974.html?x=0&.v=1

(pdf file monday June 6th 2011 page 27)...........
http://chicago2011.asco.org/MeetingProgram.aspx